675 related articles for article (PubMed ID: 2211619)
1. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.
Yoshida M; Kijima M; Akita M; Beppu T
J Biol Chem; 1990 Oct; 265(28):17174-9. PubMed ID: 2211619
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa.
Waterborg JH; Kapros T
Biochem Cell Biol; 2002; 80(3):279-93. PubMed ID: 12123281
[TBL] [Abstract][Full Text] [Related]
3. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
Wetzel M; Premkumar DR; Arnold B; Pollack IF
J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
[TBL] [Abstract][Full Text] [Related]
4. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of histone acetylation in Chlamydomonas reinhardtii.
Waterborg JH
J Biol Chem; 1998 Oct; 273(42):27602-9. PubMed ID: 9765294
[TBL] [Abstract][Full Text] [Related]
7. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S
Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520
[TBL] [Abstract][Full Text] [Related]
8. Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells.
Huang HC; Liu YC; Liu SH; Tzang BS; Lee WC
Life Sci; 2002 Mar; 70(15):1763-75. PubMed ID: 12002521
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
[TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo.
Wilson MA; Ricci AR; Deroo BJ; Archer TK
J Biol Chem; 2002 Apr; 277(17):15171-81. PubMed ID: 11821430
[TBL] [Abstract][Full Text] [Related]
12. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].
Yoshida M
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1788-9. PubMed ID: 18051427
[No Abstract] [Full Text] [Related]
13. Trichostatin A specifically stimulates gonadotropin FSHβ gene expression in gonadotroph LβT2 cells.
Oride A; Kanasaki H; Mijiddorj T; Sukhbaatar U; Miyazaki K
Endocr J; 2014; 61(4):335-42. PubMed ID: 24430728
[TBL] [Abstract][Full Text] [Related]
14. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
17. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.
Kijima M; Yoshida M; Sugita K; Horinouchi S; Beppu T
J Biol Chem; 1993 Oct; 268(30):22429-35. PubMed ID: 8226751
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines.
Hoshikawa Y; Kwon HJ; Yoshida M; Horinouchi S; Beppu T
Exp Cell Res; 1994 Sep; 214(1):189-97. PubMed ID: 8082721
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity.
Blagosklonny MV; Robey R; Sackett DL; Du L; Traganos F; Darzynkiewicz Z; Fojo T; Bates SE
Mol Cancer Ther; 2002 Sep; 1(11):937-41. PubMed ID: 12481415
[TBL] [Abstract][Full Text] [Related]
20. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W
BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
